William Taranto, President of Merck Global Health Innovation Fund (GHIF), has more than 25 years of healthcare experience –13 of which have been focused on healthcare investing. For the past two years, Merck GHIF and/or Bill Taranto have been recognized by Rock Health as one of the top 50 people or most significant investment groups that have made the largest impact on digital health.
Bill is evolving corporate healthcare venture capital globally by utilizing a healthcare ecosystem investment strategy. His group invests in platform companies with proven technologies or business models where Merck’s expertise and perspectives can accelerate revenue growth and enhance value creation. This unique investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions. In a field of investors where the average exit takes 5-7 years, MERCK GHIF has had three exits since its founding in 2010.
As President of Merck GHIF, Bill is responsible for all investments of the $500M fund, which includes more than 20 digital health companies. This portfolio consists of technology-enabled solutions and health IT platforms including decision support, provider and patient engagement, precision medicine, accountable care, health informatics and analytics, and health data liberation.